In line with results from our studies, samples from individuals treated with GAD-alum from another clinical trial (10) secreted IL4, IL5 and IL13 Th2-associated cytokines, together with IFN and IL17 (27). This evidence concerns the gene IL17A and generalized anxiety disorder.